I. Salinas

943 total citations
23 papers, 623 citations indexed

About

I. Salinas is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, I. Salinas has authored 23 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in I. Salinas's work include Thyroid Disorders and Treatments (5 papers), Growth Hormone and Insulin-like Growth Factors (5 papers) and Hormonal Regulation and Hypertension (5 papers). I. Salinas is often cited by papers focused on Thyroid Disorders and Treatments (5 papers), Growth Hormone and Insulin-like Growth Factors (5 papers) and Hormonal Regulation and Hypertension (5 papers). I. Salinas collaborates with scholars based in Spain, Russia and Australia. I. Salinas's co-authors include Anna Sanmartı́, Anna Lucas, M Foz, Jordi L. Reverter, Laura Audı́, María Luisa Granada, Núria Alonso, R. Romero, Wifredo Ricart and José Manuel Fernández‐Real and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, International Journal of Molecular Sciences and American Journal of Transplantation.

In The Last Decade

I. Salinas

21 papers receiving 601 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. Salinas Spain 13 481 207 86 70 66 23 623
M. C. Angelico United States 8 240 0.5× 202 1.0× 72 0.8× 94 1.3× 43 0.7× 13 558
Carolyn Siebert United States 7 137 0.3× 100 0.5× 150 1.7× 30 0.4× 50 0.8× 8 477
David Karásek Czechia 16 269 0.6× 253 1.2× 124 1.4× 161 2.3× 198 3.0× 89 698
Taiga Hara Japan 16 196 0.4× 142 0.7× 103 1.2× 140 2.0× 31 0.5× 35 684
Anne Kehely United Kingdom 10 192 0.4× 100 0.5× 44 0.5× 96 1.4× 46 0.7× 16 364
E Astorri Italy 16 139 0.3× 325 1.6× 127 1.5× 443 6.3× 50 0.8× 42 881
T. Steen Olsen Denmark 13 133 0.3× 128 0.6× 128 1.5× 23 0.3× 38 0.6× 21 622
N.J. van der Zijl Netherlands 10 283 0.6× 213 1.0× 95 1.1× 153 2.2× 240 3.6× 15 662
M. T. Chau China 11 243 0.5× 168 0.8× 188 2.2× 76 1.1× 138 2.1× 20 652
Ko Hanai Japan 16 253 0.5× 82 0.4× 84 1.0× 188 2.7× 117 1.8× 47 681

Countries citing papers authored by I. Salinas

Since Specialization
Citations

This map shows the geographic impact of I. Salinas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Salinas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Salinas more than expected).

Fields of papers citing papers by I. Salinas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Salinas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Salinas. The network helps show where I. Salinas may publish in the future.

Co-authorship network of co-authors of I. Salinas

This figure shows the co-authorship network connecting the top 25 collaborators of I. Salinas. A scholar is included among the top collaborators of I. Salinas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Salinas. I. Salinas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pérez‐Campos, Eduardo, et al.. (2024). O-GlcNAcylation: Crosstalk between Hemostasis, Inflammation, and Cancer. International Journal of Molecular Sciences. 25(18). 9896–9896. 5 indexed citations
2.
Alonso, Núria, María Luisa Granada, Berta Soldevila, et al.. (2010). Serum autoimmune gastritis markers, pepsinogen I and parietal cell antibodies, in patients with Type 1 diabetes mellitus: A 5-year prospective study. Journal of Endocrinological Investigation. 34(5). 340–344. 25 indexed citations
3.
Aguilera, Eva, María Luisa Granada, M.C. Pastor, et al.. (2008). Effects of GH treatment in GH-deficient adults on adiponectin, leptin and pregnancy-associated plasma protein-A.. European Journal of Endocrinology. 158(4). 483–490. 35 indexed citations
4.
Bayés, Beatriz, M.C. Pastor, Ricardo Lauzurica, et al.. (2007). Do Anti-CD25 Monoclonal Antibodies Potentiate Posttransplant Diabetes Mellitus?. Transplantation Proceedings. 39(7). 2248–2250. 14 indexed citations
5.
Bayés, Beatriz, Ricardo Lauzurica, I. Salinas, et al.. (2007). Obesity, Adiponectin and Inflammation as Predictors of New-Onset Diabetes Mellitus After Kidney Transplantation. American Journal of Transplantation. 7(2). 416–422. 68 indexed citations
6.
Reverter, Jordi L., Susana Holgado, Núria Alonso, et al.. (2005). Lack of deleterious effect on bone mineral density of long-term thyroxine suppressive therapy for differentiated thyroid carcinoma. Endocrine Related Cancer. 12(4). 973–981. 59 indexed citations
7.
Alonso, Núria, María Luisa Granada, Anna Lucas, et al.. (2004). Evaluation of two replacement regimens in primary adrenal insufficiency patients. Effect on clinical symptoms, health-related quality of life and biochemical parameters. Journal of Endocrinological Investigation. 27(5). 449–454. 23 indexed citations
8.
Alonso, Núria, María Luisa Granada, Anna Lucas, I. Salinas, & Anna Sanmartı́. (2003). Enfermedad de Addison. Tratamiento sustitutivo con glucocorticoides y su monitorización. Endocrinología y Nutrición. 50(10). 390–395.
9.
Ercilla, M.G., B. Suárez, M. Arias, et al.. (2001). Identification of a new HLA‐DRB1 allele (DRB1*0318) in three members of a Caucasian Spanish family. Tissue Antigens. 57(5). 489–491. 4 indexed citations
10.
11.
Fernández‐Real, José Manuel, et al.. (1998). Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours. Clinical Endocrinology. 49(1). 53–61. 90 indexed citations
12.
Salinas, I., et al.. (1997). Medical Therapy of Graves’ Disease: Does Thyroxine Prevent Recurrence of Hyperthyroidism?. The Journal of Clinical Endocrinology & Metabolism. 82(8). 2410–2413. 37 indexed citations
13.
Rafecas, I, José–Antonio Fernández–Löpez, I. Salinas, et al.. (1995). Insulin degradation by adipose tissue is increased in human obesity.. The Journal of Clinical Endocrinology & Metabolism. 80(2). 693–695. 7 indexed citations
14.
Romero, R., et al.. (1992). Comparative effects of captopril versus nifedipine on proteinuria and renal function of type 2 diabetic patients. Diabetes Research and Clinical Practice. 17(3). 191–198. 27 indexed citations
15.
Sanmartı́, Anna, Anna Lucas, I. Salinas, et al.. (1992). Clinical Usefulness of Urinary Growth Hormone Measurements in Normal and Short Children According to Different Expressions of Urinary Growth Hormone Data. Pediatric Research. 32(1). 73–76. 11 indexed citations
16.
Reverter, Jordi L., Anna Lucas, I. Salinas, et al.. (1992). Suppressive therapy with levothyroxinefor solitary thyroid nodules. Clinical Endocrinology. 36(1). 25–28. 81 indexed citations
17.
Sanmartı́, Anna, et al.. (1990). Effect of Chronic Clonidine Treatment on Urinary Growth Hormone Excretion and Linear Growth in Children with Short Stature. Hormone Research. 34(5-6). 193–196. 3 indexed citations
18.
Sanmartı́, Anna, Anna Lucas, I. Salinas, et al.. (1990). Assay‐Dependent Results of Immunoassayable Spontaneous 24‐Hour Growth Hormone Secretion in Short Children. Acta Paediatrica. 79(s370). 63–70. 48 indexed citations
19.
Romero, R., et al.. (1990). Long term follow-up of the effect of captopril on severe proteinuria in hypertensive diabetic patients.. PubMed. 4(6). 671–5. 6 indexed citations
20.
Romero, R., et al.. (1988). [Usefulness of angiotensin converting enzyme inhibitors in the treatment of diabetic nephropathy].. PubMed. 90(12). 494–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. C. Angelico Breakdown of academic impact, for papers by Carolyn Siebert Breakdown of academic impact, for papers by David Karásek Breakdown of academic impact, for papers by Taiga Hara Breakdown of academic impact, for papers by Anne Kehely Breakdown of academic impact, for papers by E Astorri Breakdown of academic impact, for papers by T. Steen Olsen Breakdown of academic impact, for papers by N.J. van der Zijl Breakdown of academic impact, for papers by M. T. Chau Breakdown of academic impact, for papers by Ko Hanai
Rankless by CCL
2026